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Abstract 
Adherence to antipsychotic medication has demonstrated significant impact in decreasing 
symptom exacerbation among patients diagnosed with mental illness. Antipsychotic medications 
have several benefits including the management of psychotic and mood disorders; however, they 
could cause unwanted medication side effects with metabolic and cardiovascular risks. This issue 
is one of the commonly linked side effects resulting in nonadherence among mentally ill patients. 
The purpose of this project was to implement a psychoeducational intervention using the 
SIMPLE program to address metabolic and cardiovascular risks associated with antipsychotic 
medications among adult patients diagnosed with mental illness. A sample size of sixteen adult 
patients completed this project over a four-week period. There was a significant increase in mean 
healthy lifestyle change score on pre-HPLP II (M = 16.675, SD = ± 2.385) compared to post-test 
score; HPLP II (M = 21.104, SD = ± 2.287). The findings of this project supports that 
psychoeducation promotes healthy lifestyle changes among patients prescribed antipsychotic 
medications. 
Keywords:  psychoeducation, mental illness, antipsychotic medication, metabolic risks  
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Minimizing Antipsychotic Medication Side Effects in Adults Diagnosed with Mental Illness 
through Psychoeducation: An Evidence Based Approach 
In contemporary societies, despite the tremendous strides made in the diagnosis and 
management of chronic mental health disorders such as schizophrenia and depression, a large 
section of this vulnerable population are not adherent to their treatment regimen (Owusu-Ansah 
et al., 2018). Most of the potential modifiable risk factors for non-adherence are patient-related 
such as poor insight into having a mental illness, substance abuse, lack of support system, as well 
as the patient’s personal decision to stop taking medications (Sarath, Lokesh, Pramod, & Pavan, 
2014). Another notable reason for nonadherence among a significant margin of patients 
diagnosed with mental illness is the metabolic and cardiovascular side effects of antipsychotic 
medications (Green, Janoff, Yarborough & Yarborough, 2014). Although multiple 
pharmacological interventions are available in managing symptoms, antipsychotic medications 
have proven to be very effective and is classified a cornerstone in managing the symptoms of 
psychoses, depression, and mood disorder (Annamalai, Kosir & Tek, 2017). Despite the 
immense benefits of antipsychotic medications in improving patient outcomes, antipsychotic-
induced weight gain often ensues leading to cardiovascular and metabolic syndrome.  
Background and Significance 
In the United States (US) alone, nicotine dependence, substance use disorder, and obesity 
resulted in soaring healthcare costs as well as decreased life expectancy by 10-25 years among 
people diagnosed with psychotic disorders (Erickson et al., 2017). The American Hospital 
Association (AHA), noted that health disparities among vulnerable populations continue to result 
in poorer health outcomes and increased cost across the health system (AHA, 2019). The 
healthcare costs were estimated to be $11.5 billion in 2013 (Erickson et al., 2017) with a 
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projected spending of $280.5 billion by 2020 on behavioral health treatments alone (AHA, 
2019).  
The issue of antipsychotic induced weight gain transcends geographic boundaries thus 
suggesting a diagnosis of schizophrenia as an independent risk factor for diabetes among this 
patient population even in rural areas of sub-Saharan Africa (Owusu-Ansah et al., 2018). Mental 
illness frequently causes alteration in mood and thought process leading to poor and impulsive 
dietary choices and habits (Annamalai, Kosir & Tek, 2017). Many factors are reported to 
contribute to metabolic and cardiovascular side effects among patients diagnosed with 
schizophrenia, psychosis, or schizoaffective disorder who are prescribed antipsychotic 
medications such as sedentary lifestyle, poor dietary habits and genetic susceptibility 
(Dayabandra et al., 2017). Coupled with weight gain, antipsychotics medication can cause 
elevated lipid levels and contribute to metabolic syndrome (Dayabandra et al., 2017). Metabolic 
syndrome is a combination of abdominal obesity, high blood pressure, elevated triglycerides and 
hyperglycemia (Penninx & Lange, 2018).   
Patients diagnosed with schizophrenia have double the risk of developing metabolic 
syndrome than people in the general population (Owusu-Ansah et al., 2018). Penninx and Lange 
(2018) added that second-generation antipsychotics particularly have been linked to excessive 
weight gain and risk of developing metabolic syndrome resulting in increased morality among 
mentally ill patients. National Institute for Health and Clinical Excellence (NICE) noted that 
increased metabolic and cardiovascular side effects are sometimes not a result of antipsychotic 
medication alone but also the result of a diet which is low in fruits and vegetables as well as a 
life with little to no physical activity (NICE, 2014). Psychoeducation empowers patients with 
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information and in recent times has developed as an aspect of treatment of schizophrenia with 
the goal of improving overall patient outcome (NICE, 2014).  
Evidence-Based Intervention 
Psychoeducation is a form of patient education/teaching which can be delivered in 
multiple formats such as in print or verbally (Bäuml et al., 2016). Unlike other forms of patient 
education offered to patients in print or verbal form, psychoeducation is an evidence-based form 
of patient-centered care where patients and their families are offered attainable and practical 
options towards improving overall wellbeing. The most important tenet of psychoeducation is to 
ensure the manner in which this information is provided is well understood by the intended 
audience. Bäuml et al. (2016) explained that psychoeducation often improves adherence and 
motivates patients to strive for optimal wellbeing. The studies discussed in this project report 
utilized psychoeducation as an evidence base practice (EBP) intervention with a patient-centered 
care focus. By selecting psychoeducation as an intervention, patients prescribed antipsychotic 
medications have the opportunity to understand and implement healthy lifestyle changes with the 
aim of managing antipsychotic medication-induced metabolic side effects.  
Purpose Statement 
The purpose of this EBP change project was to implement a psychoeducational 
intervention to address the problem of metabolic and cardiovascular risks associated with 
antipsychotic medications among adult patients diagnosed with mental illness. The goal of the 
project was to analyze the impact of group psychoeducational intervention on physical activity 
level and fruit/vegetable intake as well as evaluate the effectiveness of psychoeducation on 
healthy lifestyle changes among adult patients diagnosed with mental illness and prescribed 
antipsychotic medications.  
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Theoretical Framework 
The theoretical framework which guided the implementation of this evidence-based 
project (EBP) was Kurt Lewin’s Change theory which was introduced in the 1940s (Lewin, 
1999; McEwen & Wills, 2014). This theory provided the foundation for effective 
implementation of change by an individual or an entire group of people (McEwen & Wills, 
2014). In order for an individual with a new or currently existing diagnosis of mental illness to 
adhere to lifestyle changes through psychoeducation which has the potential to improve 
outcome, that person would need to go through a transformational change. This change process 
goes beyond the superficial alterations which are easily noticeable to address the mental and 
emotional need to attain wellness.  
Lewin’s Change theory is guided by three core concepts; driving forces, restraining 
forces and equilibrium (Lewin, 1999). Lewin explained that driving force assists/accelerates 
movement into the desired direction while the restraining force acts as an obstacle or stumbling 
block to the new change process. This usually causes tension and imbalance however when a 
state of equilibrium is reached both driving and restraining forces are equal resulting in no 
change. McEwen and Wills (2014) added that it is essential for opposing/restraining forces to be 
identified and eventually minimized so that the desired effect of change is achieved. Thus a 
patient’s desire to attain optimal wellness acts as the driving force for medication/treatment 
adherence while the restraining force of antipsychotic-induced weight gain/obesity pulls the 
patient away from absolute compliance. Adapting the tenets of Lewin’s Change theory through 
psychoeducation, patients were provided with the necessary tools needed to maneuver and 
master the art of adherence to prescribed antipsychotic medication regimen while managing the 
metabolic and cardiovascular medication side effects in a healthy manner.    
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Lewin utilized three major stages of change; (unfreezing, moving, and refreezing) to 
explain the complex processes an individual has to go through for lasting change to occur 
(Lewin, 1999). The first stage of change, unfreezing, helps the patient understand the need for 
change (White, 2014). The unfreezing stage is an important phase in the change process 
especially as it has the tendency to decrease resistance to change if the patient affected by this 
change is adequately educated about the need for change. During this phase, patients prescribed 
antipsychotic medications were educated on the positive impact of adherence to antipsychotic 
medication regimen as prescribed. A candid overview of the potential metabolic and 
cardiovascular side effects of antipsychotic medications were discussed with patients. Patient’s 
current dietary habits as well as physical activity level were assessed. Effective communication 
was a necessity during this stage so that the patient who was affected by this change understood 
the rationale behind its initiation. After creating an awareness of the need for change during the 
unfreezing stage, White (2014) explained that the second stage, the moving stage, focuses on 
strengthening the environment in order for change to occur. This stage introduced or reinforced 
healthy lifestyle options which guided patients prescribed antipsychotic medications. The final 
stage of Lewin’s change theory, the refreezing stage, became an opportunity to revisit results of 
the lifestyle change, discuss challenges encountered or still facing, areas requiring alterations as 
well as planning for the way forward (Manchester et al, 2014).  
Lewin and Gold (1999) added that although any planned social change will have to 
consider multiple factors there is still the need to ensure that reinforcement of the new patterns 
are formally/informally instituted so that patients can conveniently reference in time of need. 
Diligently educating patients prescribed antipsychotic medications about the need for healthier 
lifestyle options through psychoeducation has the potential not only to move communities and 
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the nation closer towards wellness but could lead towards preserving lives and improving overall 
patient outcomes. 
Literature Review 
A literature search was conducted for this EBP project primarily through CINAHL, 
PubMed, Medline, and Cochrane Collaboration. The keywords used during the initial search 
included: metabolic side effects, antipsychotic-induced weight gain, and antipsychotics which 
yielded less than four relevant systematic review articles and five randomized controlled trials 
(RCTs). Other key words such as psychoeducation, lifestyle changes, obesity, diet, and atypical 
antipsychotics were included in the search criteria. The five studies chosen were all RCTs 
published within the past five years with similar underlying theme. The studies utilized 
psychoeducation and lifestyle changes as an intervention to manage/counteract the metabolic and 
cardiovascular side effects of antipsychotic medications. 
Bersani et al. (2017) evaluated the clinical effectiveness of an educational intervention 
targeting lifestyle habits in patients with mood and psychotic disorders. This RCT utilized a 
double-blinded study design and adopted a theoretical framework based on a heuristic approach. 
A sample size N=32 adults ages 18-65 were recruited at the day hospital of the psychiatric 
department at University Hospital in Rome, Italy. Inclusion criteria for these participants were a 
diagnosis of major depressive disorder, schizophrenia, and bipolar disorder. The intervention 
group’s sample size n=16 received specialized educational sessions on healthy lifestyle changes 
on diet, physical activity, and overall wellness while the control group’s sample size n=16 
received non-specific psychoeducation on medication management or discussed patient’s clinical 
outcomes (Bersani et al., 2017). The variables in this study included psychoeducation, lifestyle 
habits, cardio-metabolic disturbances and individuals with psychiatric disorder. Three 
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measurement tools used in this study were the Pittsburgh Sleep Quality Index (PSQI), 
International Physical Activity Questionnaire (IPAQ), and Brief Psychiatric Rating Scale 
(BPRS). The PSQI is a group of 19-self-rated questions grouped into seven clinically derived 
domains of sleep difficulties and each of the seven domains is equally rated on a Likert scale of 
0-3 to generate a global score of 0–21 where global PSQI score > 5 is indicative of poor sleep 
quality. The IPAQ is a self-report measure rating the number of minutes spent exercising per day 
in the previous week, and the intensity level of the exercise while the BPRS is an extensively-
validated clinician-rated scale using a 7-point Likert scale. Analysis of the intervention group 
showed a significant positive change from baseline while scores of subjects in the control group 
did not change significantly over time. Level of significance and confidence interval (CI) were 
not stated. Findings for the study deduced decrease cardio metabolic disturbances related to 
psychoeducation. This study reinforced that psychoeducation decreased a patient’s risk of other 
cardiovascular diseases through lifestyle changes which led to improvement in overall health 
status (Bersani et al., 2017). 
Curtis et al. (2016) studied the effectiveness of a lifestyle and life skills intervention 
delivered within four weeks of antipsychotic medication initiation in attenuating weight gain in 
youth aged 14–25 years with first-episode psychosis. A motivational framework was used in this 
RCT with prospective-controlled design. Young people ages 14-25 (N=28) were randomly 
selected from two community-based first-episode psychosis (FEP) services with treatment with 
antipsychotic medication for less than four weeks prior to baseline assessment. The intervention 
group’s sample size n=16 while the comparison group’s sample size n=12. The intervention 
group received health coaching, dietetic support and supervised exercise prescription.  The 
control group received standard care which involved individual mental health case management 
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with medical assessment of prescribed antipsychotic medication following standard clinical 
guidelines. Some of the dependent and independent variables included individualized lifestyle 
and life skill, and psychoeducation. Overall, subjects in the intervention group reported lower 
weight gain of 1.8kg compared to subjects in the control group who reported weight gain of 
7.8kg. The study reported a moderate effect size with 95% CI. The outcome of the study 
portrayed decreased weight gain related to psychoeducation on individualized lifestyle and life 
skill. The authors reinforced that implementing effective lifestyle and life skills interventions 
from the initiation of treatment as part of routine care has the potential to result in improved 
patient outcome. 
Erickson et al. (2017) studied the behavioral interventions for veterans with mental 
illness and antipsychotic medication-associated obesity. This RCT utilized a sample size of 121 
adults mainly male veterans with some non-veteran women ages 18-70. Research activities took 
place in research offices near mental health clinics at the Greater Los Angeles Veterans 
Administration (VA) and VA Long Beach Healthcare Systems and the participants had to have a 
diagnosis of mental illness per DSM-IV, antipsychotic drug treatment, Body mass index (BMI) > 
25, or weight > 7% on antipsychotic drugs. The major variables in this study were 
psychoeducation, behavioral intervention, and lifestyle balance. One of the measurement tools 
used was Self-Appraisal of Illness Questionnaire (SAIQ) which is a self-report instrument 
designed to assess attitude towards mental illness among people receiving psychiatric 
treatment. All clinical scores decreased over time; SAIQ showed a significant association with 
treatment effect on weight change with higher scores associated with larger weight loss. The 
study had a small effect size with 80% CI and reported decreased cardiovascular and metabolic 
disturbances related to behavioral interventions on antipsychotic medication-associated obesity. 
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Overall patient outcome would improve through routine education (oral/verbal and in 
written/printed literature) on the benefits of healthy lifestyle choices while taking antipsychotic 
medication. 
Green, Janoff, Yarborough and Yarborough (2014) tested the acceptability/feasibility of 
the PREMIER/DASH Diet intervention among people taking antipsychotic medications as well 
as tested the hypothesis that the intervention was more effective than usual care in reducing 
weight. This RCT utilized motivational and behavioral change theories as its conceptual 
framework. A sample size of 121 adults older than the age of 21 were recruited from a large, not-
for-profit, integrated health plan in the US. The BMI range for participants was 24 - 44.9 and had 
to be taking at least one antipsychotic medication at any consistent dose for a minimum of 
30 days. The major variables in the study were lifestyle changes and psychoeducation with 
intervention and control participants completing study questionnaires at baseline and post-
treatment. The measurement tools used in this study were Eating Habits Confidence Survey 
(EHSC), Exercise Confidence Questionnaire (ECQ), Social Support for Diet and Exercise 
Behaviors (SSDEB), and Wisconsin Quality of Life -Medication Adherence Items (W-QLI). The 
mean weight in the intervention group declined from 213.3 to 206.6 pounds, a mean reduction of 
6.7 pounds (SD = 6.0). Level of significance and confidence interval (CI) were not stated. 
Although this study used a small sample size, the study was of a pilot nature, and the participants 
in the study were insured population and it would be premature to generalize the results to other 
populations or settings, this RCT yielded similar findings in a study that occurred within an 18-
month timeframe which deduced that lifestyle and diet changed produced positive results in 
patients prescribed antipsychotic medications. 
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 Kreyenbuhl et al. (2017) conducted a RCT of a computerized, patient-centered 
intervention aimed at educating veterans with serious mental illness about the metabolic side 
effects of antipsychotics and encouraging them to advocate for receipt of guideline-
recommended side effect monitoring. The study used the patient-centered care framework with a 
sample size of 240 veterans ages 18-70 at two Veterans Affairs outpatient mental health clinics 
in the Mid-Atlantic region of the Unites States. In addition to the psychiatric diagnoses of 
participants, veterans with a diagnosis of posttraumatic stress disorder (PTSD) were included in 
the study as well as those prescribed one or more oral or injectable second generation 
antipsychotic. The independent and dependent variables in this study were educational program 
and lifestyle change. Responses were rated on a 5-point scale (0–4), with higher scores 
representing greater symptom severity.  Psychiatric symptom severity over the past week was 
measured by the average score of the 24-item using Behavior and Symptom Identification Scale 
(BASIS-24). Level of significance and confidence interval (CI) were not stated. The study noted 
increased screening request from veterans for antipsychotic medication metabolic side effects 
related to psychotherapy. Findings from the study supported the fact that individuals with serious 
mental illness are interested in obtaining personalized information about their cardio-metabolic 
status. 
Synthesis of the Literature 
Although five RCTs were reviewed with a wide range of similarities in their proposed 
EBP intervention, they still possessed marked differences which were unique to each study. 
Erickson et al (2017); Green et al. (2014) and Kreyenbuhl et al. (2017) randomly selected large 
sample sizes between 121 and 240 participants ensuring generalization of their findings while 
Curtis et al. (2016) and Bersani et al. (2017) had smaller sample sizes of 28-32 participants. 
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Participants in all the studies were classified as adults between the ages of 18- 65/70 years except 
for the study by Curtis et al. (2016) which sampled youth between the ages of 14-25 especially 
since the focus of the study was on the youth population with FEP. The inclusion criteria of all 
the studies stressed on an underlying diagnosis of mental illness with diagnoses of schizophrenia, 
bipolar disorder, depression, and schizoaffective disorder however Kreyenbuhl et al. (2017) 
added an additional diagnosis of PTSD. Although an underlying inclusion criteria for 
participants in all the studies was receiving a prescription of antipsychotic medications and did 
not specify but assumed an oral form of antipsychotic, Kreyenbuhl et al. (2017) was the only 
study which specified that the antipsychotic medication had to be second-generation 
antipsychotic which could be administered orally or through a long-acting injectable. Kreyenbuhl 
et al. (2017) further narrowed down participants for their study with the aimed at ensuring that 
study findings could be adapted on a broad scale in that second-generation or atypical 
antipsychotics have more notoriety for causing metabolic/cardiovascular side effects compared 
to typical antipsychotics which produce more extrapyramidal symptoms (EPS).  
 All five studies used for this literature review adopted the same EBP intervention which 
stressed on the effect of psychoeducation on lifestyle changes among participants to decease 
metabolic and cardiovascular side effects of antipsychotic medications. Through 
psychoeducation on lifestyle changes, Bersani et al. (2017), Curtis et al. (2016), Green et al. 
(2014) and Erickson et al. (2017) reported participants experienced improved sleep habit, 
decreased weight/BMI, as well as increased physical activity/exercise however Kreyenbuhl et al. 
(2017) did not utilize direct psychoeducation on lifestyle changes. Participants in the study by 
Kreyenbuhl et al. (2017) were encouraged to request frequent laboratory screening for fasting 
blood glucose and lipid panel in order to detect any changes in metabolic function. Another 
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deviation of this study from all the other studies was that unlike the other four studies which 
reported decreased cardiovascular and metabolic risks related to psychoeducation, Kreyenbuhl et 
al. (2017) reported increased weight gain and metabolic risks in spite of frequent request for 
laboratory screenings. Increased knowledge on healthy lifestyle choices was however noted in all 
participants of the various studies.  
Agency Description 
Setting 
 The project implementation occurred in an outpatient behavioral health clinic in Las 
Vegas, Nevada in spring 2020. The clinic provides care to a large number of clients with diverse  
mental illness. The setting for this EBP project was a mental health clinic located in the Las 
Vegas Valley. The clinic serves clients over the age of six years to geriatric population. The 
common diagnoses managed at the clinic include bipolar disorder, depression, schizophrenia, 
substance abuse, posttraumatic stress disorder, attention deficit hyperactive disorder and anxiety 
disorder.  
All clients served at the clinic have some form of private, state or federal-funded health 
insurance while others are private pay clients. Some of the clients are homeless residing at 
Catholic Charities or the Salvation Army who have health insurance coverage. The clinic is 
conveniently located on the public transportation route with primary care outpatient clinics as 
well as other healthcare facilities within close proximity. The setting was selected for 
implementation of the project because of patients’ subjective reports and objective assessment of 
antipsychotic induced medication side effects.  
Target population 
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 Participants in this EBP change project were English-speaking adult patients over the 
age of 18 diagnosed with mental illness and prescribed at least one antipsychotic medication. 
Participants were welcomed from all ethnic backgrounds with no gender or religious preference. 
Congruence of project to agency’s mission, goals, and strategic plan 
 Metabolic and cardiovascular risks associated with antipsychotic medication raises 
concern among patients and healthcare providers. Melnyk and Fineout-Overholt (2015) 
highlighted that internal evidence such as patient’s clinical status/circumstances, patient’s 
preferences, and outcomes of quality improvement projects should be considered during clinical 
decision making. For this project, in addition to patients’ subjective reports of weight gain and 
exacerbation of underlying disease processes related to prescribed antipsychotic medication, 
patient’s current dietary habits, as well as physical activity level were analyzed prior to delivery 
of psychoeducational intervention. This internally generated data was compared with national 
and global statistics of the problem of antipsychotic induced metabolic/cardiovascular risks and 
its impact on society as a whole.  
Stakeholders 
 The interprofessional team at the practice change site included psychiatrists, doctoral 
prepared nurse practitioners, medical assistants, an office manager, information technology (IT) 
personnel as well as accounting/billing department. Team members participated in this project 
according to their scope of practice and job description. The psychiatrists and other nurse 
practitioners referred interested patients prescribed antipsychotic medications to the Principal 
Investigator (PI) who was responsible for providing psychoeducation. Scheduling of participants 
for this project was the responsibility of the medical assistants. The preceptor for this project 
served as a resource for the PI while Information Technology (IT) personnel assisted in 
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retrieving a list of past and current antipsychotic medication record from the electronic medical 
records (EMR) as needed. Project participants constituted an important group of this project’s 
stakeholders whose understanding and implementation of the psychoeducational intervention 
was evaluated at the end of the entire project. 
Project Design 
 This study utilized a pretest-posttest design. A weekly log tracking daily fruit and  
vegetable intake as well as minutes of physical activity was collected at the start of this 
educational intervention and throughout the four-week session. In week one of the group 
sessions, data collected from HPLP II acted as baseline assessment. At the end of the 4-week 
psychoeducational session, HPLP II was collected again to analyze whether participants gained 
or adapted healthy lifestyle changes based on psychoeducation received. Data was collected by 
the PI who was solely responsible for providing psychoeducation to participants during the 
project implementation phase. The project utilized mixed data collection methods which 
included questionnaire and anthropometric data. Data from the HPLP II was collected from 
participants through a questionnaire while the data collection form was used by participants on 
the first and last day of the psychoeducation session.  
Methods 
Evidence-Based Intervention: SIMPLE Program 
The psychoeducational intervention which was used for this evidence-base practice 
(EBP) project is the Simplified Intervention to Modify Physical activity, Lifestyle, and Eating 
behavior (SIMPLE). SIMPLE is originally a 16-week lifestyle program focused on physical 
activity and nutritional education which provided weight loss support as well as teaching on 
healthy eating habits (Jean-Baptiste et al., 2007). This intervention was tailored within a four-
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week timeframe for participants to achieve maximum benefit. The program author provided 
permission for changes to be made to the length of the program. The educational program is 
independent of prior educational level, socioeconomic status as well as baseline cognition and 
trains patients diagnosed with mental illness and prescribed antipsychotic medication how to 
read food labels, prepare meals and practice portion control manage the metabolic medication 
side effects (Jean-Baptiste et al, 2007). Written permission to use this educational tool was 
sought and approved by Dr. Cent Tek with the stipulation to provide due reference to this 
project. A resource manual describing this intervention as well as handouts for participants were 
available for free downloads from the internet at no cost. 
Implementation Framework 
 The selected model for the EBP project was the Model for Evidence-Based Practice. The 
Model for Evidence Based Practice, a revised version of the model by Rosswurm and Larrabee 
integrated the principles of quality improvement, utilization of team work tools and evidence-
based translation to promote practice change (Larrabee, 2009).  This EBP change model was 
preferred because offered an in-depth, robust six-step process that guided practice change project 
implementation. This model assessed the need for planned change within the practice site, 
located the best evidence, critically analyzed the evidence, designed a practice change, 
implemented and evaluated change in practice as well as integrated and maintained change in 
practice (Larrabee, 2009). The project was categorized into four main stages which included 
development and analysis of the intervention, an assessment of the practice site, implementation 
of the psychoeducational intervention and evaluation of the effectiveness of the intervention. 
Procedures 
IRB Submission Process 
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 An expedited review application for Internal Review Board (IRB) approval was obtained 
from Eastern Kentucky University (EKU) before the beginning of this project. After receiving 
approval from EKU’s IRB, patients were recruited by referral from other prescribers at the 
clinical site as well as through an open invitation process. 
Recruitment 
 Following IRB approval of the project, participants were recruited for this project 
through a cover letter offered to patients upon clinic check-in. Adult patients who were English-
speaking and prescribed antipsychotic medications were provided with a cover letter as they 
waited in the lobby for their scheduled appointment. The cover letter included an overview of the 
project and patients were directed to the front desk who were interested in the study or met 
criteria. A meeting with the PI was scheduled to discuss details of this project.  
Measures and Instruments  
Health-Promoting Lifestyle Profile II (HPLP II). The instrument which was used to 
measure the effectiveness of SIMPLE as an effective psychoeducational tool among project 
participants was the Health-Promoting Lifestyle Profile II (HPLP II). HPLP II was originally 
designed by Walker, Sechrist, and Pender in 1987 and later revised in subsequent years. This 
measurement tool is a 52-item utilizing a four-point response scale to assess the frequency of 
self-reported health-promoting behaviors (Walker et al., 1987). The 52-items in this tool are 
grouped into six subscales in the domain of stress management, interpersonal relations, physical 
activity, nutrition, health responsibility and spiritual growth (Walker et al., 1987).  
The four-point response scale which can be self-administered is itemized as; never, 
sometimes, often, and routinely and is tallied by calculating the mean of all 52 items (Walker & 
Hill-Polerecky, 2011). Walker and Hill-Polerecky (2011) added that in order to retain the metric 
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of item responses and ensure meaningful comparison scores across subscales, the use of means 
rather than the total of scale items is preferred. The higher the score, the greater the 
improvement. Walker and Hill-Polerecky (2011) calculated the test-retest reliability of the 
HPLP II as 0.892 after a three-week interval. They also reported the internal consistency as 
Cronbach’s alpha 0.943, while the subscales range from 0.793-0.872. Walker and Hill-Polerecky 
(2011), performed several validity measures which was confirmed by factor analysis. These 
analyses confirmed the six-dimensional structure of HPLP II which was also supported 
by convergence with the Personal Lifestyle Questionnaire (r = 0.678) as well as a nonsignificant 
correlation with social desirability. The HPLP II has significant criterion validity with concurrent 
measures of perceived health status and quality of life (r = 0.269-0.491). A written request for 
permission to use this measurement tool was sent to Dr. Sechrist and Dr. Pender and permission 
was granted. In addition to the HPLP II questionnaire, other data collected included 
demographics on gender, age, current dietary and exercise habits.  
Data collection form. During this project, a data collection form was provided to 
participants on the first and last day of the psychoeducational session. The form collected 
information on gender and age of participants as well as list of antipsychotic medications. 
Participants also completed a weekly log which tracked their daily fruit and vegetable intake as 
well as minutes of physical activity. 
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Program Evaluation Form. A post-psychoeducational intervention evaluation form was 
completed by participants on the last day of the group sessions. Participants evaluated the 
psychoeducational sessions and whether they adopted healthy lifestyle changes due to the 
knowledge gained from the SIMPLE program.  
Implementation  
The psychoeducational sessions were advertised with a recruitment flyer positioned at the 
check-in window of the outpatient clinic. The project consisted of group psychoeducational 
sessions held on Tuesday and Thursday evenings for 30-45 minutes. The Tuesday sessions were 
identical to the sessions on Thursday which provided participants flexibility in group attendance. 
The sessions were held over a 4-week period and each participant was expected to participate in 
four out of the eight sessions offered. During the first session, participants required an extra 30 
minutes to sign informed consent and fill out demographic forms. The HPLP II was administered 
to participants prior to beginning the first psychoeducation session as well as during the final 
psychoeducational session.  
During the first week, participants were educated on the benefits of antipsychotic 
medications and provided an overview of the metabolic and cardiovascular side effects of this 
class of medication. The second week’s psychoeducational group session focused on realistic 
dietary changes where participants were taught how to read food labels, meal planning, keep 
food journals, understand portion control as well as provided budget friendly food shopping tips. 
The third week of the group sessions addressed physical activity and highlighted tips on how to 
increase physical activity and have fun. In week four which was the final week of the group 
sessions, participants were provided tips on how to control hunger and deal with cravings. Ideas 
MINIMIZING ANTIPSYCHOTIC SIDE EFFECT  24 
 
on how to identify personal support system was discussed and the weekly sessions were 
summarized.  
 
Data Analysis 
Data analyses was conducted using IBM SPSS® software version 25. Two tables of 
paired t-Tests were computed to compare pre and post test results. Indicators for metabolic and 
cardiovascular risk factors, dietary habits, and physical activity level as well as responses to 
HPLP II pre and post psychoeducational intervention was measured. Pre and post HPLP II 
questionnaire scores was analyzed using paired t-test to determine the level of significance. 
Paired t-test for all the six subscales was calculated individually to determine whether any 
significant change existed. Using a paired sample t-test, pre and post data on daily consumption 
of fruits/vegetables as well as physical activity level was analyzed for significance. 
Results 
A total of 16 participants completed the pre and post-test assessment. There were 7 
females and 9 male participants within the age range of 23 to 60 years of age; with a mean age of 
43. (Table 1). 
Table 1 
Demographic Characteristics of Participants (N = 16) 
 
Characteristic 
 
 
n 
 
percentage 
 
 
  
                   Male                        9                  56.2 
                    
                   Female 
                        
                        7 
                  
                 43.8 
                    
                   Age (M) 
                        
                       43 
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Health Promotion Lifestyle Profile II (HPLP II) 
 Participants’ responses on the HPLP II before and after the psychoeducational 
intervention were analyzed using paired-t tests. Results of the paired t-test are presented in Table 
2 which compared the pre and post intervention assessment of the HPLP II subscales as well as a 
paired sample t-test for the overall HPLP II. There was significant increase in pre-test score for 
HPLP II (M = 16.675, SD = ± 2.385) compared to post-test score for HPLP II (M = 21.104, SD = 
± 2.287). The overall mean difference was 4.729 with a 95% confidence interval (CI) as well as 
Cohen’s d of (1.66) which indicated a Large effect size (Table 2). 
Table 2 
Paired Samples t-test for the Total and Subscales of Health-Promoting Lifestyle Profile II 
HPLP II Scale Mean SD Mean 
difference 
SD t df p 
 
Pre-HPLP II 
(overall) 
 
16.675 
 
2.385 
 
4.729 
 
2.841 
 
16.308 
 
95 
 
< .001 
Post HPLP II 
(overall) 
21.104 2.287      
 
Pre-Stress 
Management 
 
16.563 
 
1.896 
 
4.125 
 
1.408 
 
11.716 
 
15 
 
<. 001 
Post-Stress 
Management 
20.688 1.448      
 
Pre-Nutrition 
 
16.75 
 
2.745 
 
4.5 
 
3.54 
 
5.084 
 
15 
 
< . 001 
Post-Nutrition 21.25 2.408      
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Physical activity. The results depict an increase in amount of time engaged in physical 
activity among the 16 participants who completed the project. The mean physical activity 
minutes for the 16 participants at the start of the project was 48.125 minutes, and the mean at the 
end of the project was 67.5 minutes. Paired sample t-test for comparing time spent in physical 
activity before and after the intervention was statistically significant p = .0033 (Table 3).  
Table 3 
Paired Samples t-Test Results for Physical Activity Reported for Project Duration 
HPLP Scale Group 
Means 
 
SD Mean 
Difference 
SD t df   p 
 
Pre-Physical 
Activity 
 
 
48.125 
 
32.958 
 
19.375 
 
24.622 
 
3.148 
 
15 
 
.0033* 
Pre- 
Interpersonal 
Relationship 
 
16.125 
 
2.125 
 
4.25 
 
1.238 
 
13.729 
 
15 
 
< .001 
Post-
Interpersonal 
Relationship 
20.375 2.391      
 
Pre-Physical 
Activity 
 
16.875 
 
3.612 
 
4.625 
 
5.227 
 
3.54 
 
15 
 
.0015 
Post-Physical 
Activity 
21.5 3.183      
 
Pre-Health 
Responsibility 
 
16.188 
 
1.721 
 
-5.5 
 
1.673 
 
-13.148 
 
15 
 
< . 001 
Post-Health 
Responsibility 
21.688 1.621      
 
Pre-Spiritual 
Growth 
 
15.75 
 
1.844 
 
5.375 
 
1.784 
 
12.05 
 
15 
 
< . 001 
Post-Spiritual  
Growth 
 
21.125 2.336      
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Post-Physical 
Activity 
 
67.5 23.944      
Note. * significant p value. 
Fruits and vegetables intake. The project’s results showed that there was as increase in 
fruits/vegetables intake among the 16 participants who completed the project. The mean 
fruits/vegetable intake for the 16 participants at the start of the project was 1.047 cups, and the 
mean at the end of the project was 1.656 cups. Paired sample t-test for comparing 
fruits/vegetables intake before and after the intervention was statistically significant p < .001 
(Table 4).  
Table 4 
Paired Samples t-Test Results for Fruits/Vegetables Intake Reported for Project Duration 
HPLP Scale Group 
Means 
 
SD Mean 
Difference 
SD t df   p 
 
Pre-
Fruits/Vegetable 
Intake 
 
 
 
1.047 
 
 
0.621 
 
 
0.609 
 
 
0.612 
 
 
3.982 
 
 
15 
 
 
< .001* 
Post-
Fruits/Vegetable 
Intake 
 
 
1.656 
 
0.612 
     
Note. * significant p value. 
Program evaluation. A post-psychoeducational intervention evaluation form was 
completed by all sixteen participants on the last day of the group sessions. All participants 
(100%), reported the sessions provided an overview of the antipsychotic medications and 
explained the metabolic and cardiovascular side effects of antipsychotic medication. All the 
participants (100%), reported the sessions provided tips on healthy dietary habits and ways on 
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how to increase physical activity. All participants (100%), reported the group sessions resulted in 
substantial healthy lifestyle changes through diet and exercise. 
Discussion 
 Several RCTs (Bersani, 2017; Curtis, 2016; Erickson, 2017) and clinical research 
(Penninx, 2018) support the need to utilize healthy lifestyle changes and life skills through 
psychoeducation to mitigate the metabolic side effects of antipsychotic medications. The 
literature reviewed in this project highlighted the positive impact psychoeducation which 
emphasized increased physical activity as well as healthy dietary choices had on the overall 
wellbeing of patients prescribed antipsychotic medications (Bersani et al., 2017). The findings 
from this project are consistent with the literature. Participants reported improvement in the 
amount of time they were engaged in physical activity as well as increased their intake of 
fruits/vegetables over the four-week period of this project. Based on the outcome of this project, 
utilizing non-pharmacological interventions such as psychoeducation with an emphasis on 
behavioral and lifestyle modification through dietary changes and physical activity can increase 
awareness and encourage behavioral changes on ways to manage antipsychotic medication 
metabolic side effects.  
Limitations 
 The project sample size (n=16) represented a small fraction of the target patient 
population which could have benefited from this project. The four-week timeframe for project 
implementation and evaluation was not adequate to  assess the long term benefit of the 
psychoeducational program to participants. Participants’ personal assessment of fruit/vegetable 
intake as well as physical activity level also posed a limitation to the project due to possible 
discrepancies in reporting. The community impact of the COVID 19 pandemic caused anxiety 
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among participants leading to two participants terminating their involvement in the project at the 
end due to underlying medical conditions which affected project sample size.   
Implications 
Clinical Practice 
 The EBP project focused on educating participants on practical ways to minimize 
antipsychotic medication side effect through psychoeducation. The intervention was successful 
in improving patient outcomes as evidenced by the post-intervention data and is aligned with the 
overwhelming support for psychoeducational intervention in already existing literature (Bersani 
et al., 2017; Curtis et al., 2016; Erickson et al., 2017). This four-week project although brief in 
time frame, suggested benefits for a longer duration of a similar project. The DNP-prepared 
nurse could thus play a leading role in identifying, implementing and sustaining facility wide 
changes which would improve the overall wellbeing among the vulnerable mentally ill patient 
population.  
Policy 
At the local, state and national levels, advocacy for legislations and programs which 
would improve health literacy through patient education especially among patient diagnosed 
with mental illness needs to be to be considered. Programs focused on psychoeducation 
explaining the need for treatment compliance and ways to minimize medication side effects 
among vulnerable populations could bridge the health disparity gap among patients diagnosed 
with mental illness. According to the American Association of Colleges of Nursing (AACN), 
one role of the DNP-prepared advance practice nurse is to become an innovative leader in the 
transformation of the current health care system (AACN, 2004). The DNP prepared nurse must 
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be prepared and ready to lead, collaborate and advocate with the goal of improving patient and 
healthcare outcomes.  
Quality and Safety 
A primary diagnosis of mental illness such as Major Depression, Bipolar Disorder, and 
Schizophrenia could contribute to an increased risk of premature death resulting in 2-3 times 
higher mortality rate among this vulnerable population (Pringsheim et al., 2017). According to 
the literature, cardiovascular conditions account for a portion of this elevated mortality rate 
(Curtis et al., 2016; Erickson et al., 2017) but the good news is that there are modifiable risk 
factors which could be used to mitigate these metabolic and cardiovascular conditions. Among 
the general population, management of cardiovascular conditions are challenging but it is 
significantly problematic among patients diagnosed with severe mental conditions.  
In addition to psychoeducation on health lifestyle changes, healthcare providers are 
encouraged to routinely monitor patients at risk for metabolic and cardiovascular side effects 
originating from prescribed antipsychotic medications (Pringsheim et al., 2017). Adhering to 
evidence-based guidelines on appropriate screening protocol and antipsychotic safety monitoring 
would not only decrease antipsychotic medication side effects but eventually save lives 
((Pringsheim et al., 2017). 
Education 
Implementation of EBP leads to quality care and best outcomes, reduces cost and 
disparity, empowers clinicians and increases role satisfaction (Melnyk & Fineout-Overholt, 
2015).  Continuity of seeking and implementing current best evidence is imperative to prevent 
outdated treatment that will lead to poor patient outcomes. The DNP-prepared nurse must 
continue to implement practice change projects, educate patients and caregivers, advocate policy 
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changes that sustains EBP change and embrace new evidence to combat non-adherence.  It will 
be beneficial for future work to recognize the role of families/caregivers. Providing 
psychoeducation to the entire family/caregivers on the need to include healthy lifestyle changes 
in the lives of patients prescribed antipsychotic medications will be more effective than an 
individual session.  
 
Sustainability 
Long term strategies are needed in order to sustain a project change. Upon completion of 
this EBP change project, the PI and stakeholders at the implementation site are considering a 
number of approaches to sustain the positive changes that were achieved. These approaches 
include the addition of psychoeducational groups to treatment as usual for patients prescribed 
antipsychotic medications. Psychiatrists, APRNs, and Physician Assistants (PA) at the clinical 
site will recommend psychoeducational sessions to patients/caregivers, and front office staff 
have been assigned to compile names for the Licensed Clinical Social Workers (LCSW) who 
will develop group sessions involving prescribers as well.  Participants who took part in the 
recently completed EBP change project will be given the opportunity to participate, with the goal 
of reinforcing what was previously learned.   
Future Scholarship 
Collaboration among a wide range of mental health providers is planned to engage a 
larger number of participants and to implement future projects in a larger area of the community.   
Poster presentations at professional organizations comprising mental health providers such as 
American Psychiatric Nurses Association (APNA) Nevada chapter will be utilized to accomplish 
this goal.  Psychoeducational intervention must be added to treatment as usual for patients 
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prescribed antipsychotic medications. Patients are more likely to adhere to their treatment 
regimen if they have a better understanding of how to mitigate and manage unwanted medication 
side effects. 
Conclusion 
The consequences of antipsychotic induced medication cardiovascular and metabolic side 
effects are dire. Utilizing psychoeducation during treatment as usual can be an effective 
intervention in improving adherence to medications regimen as well as decreasing these 
unwanted medication side effects. Psychoeducational interventions are designed to impart 
knowledge on antipsychotic medication metabolic side effects and its management through 
lifestyle changes. The pre-test and post-test data analysis among participants before and after the 
project intervention reinforce that psychoeducation positively impacts lifestyle changes among 
patients prescribed antipsychotic medications. Implementing the tenets of this project at the 
practice site as well as other behavioral health sites could manage the metabolic and 
cardiovascular side effects from antipsychotic medications and eventually improve overall 
wellbeing for patients diagnosed with mental illness. 
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